FREE Account Opening + No Clearing Fees
Loading...

Akums Drugs and Pharmaceuticals IPO vs Emcure Pharma IPO

Comparision between Akums Drugs and Pharmaceuticals IPO and Emcure Pharma IPO.

IPO Details

Akums Drugs and Pharmaceuticals IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Emcure Pharma IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Akums Drugs and Pharmaceuticals IPO is up to ₹1,856.74 Cr whereas the issue size of the Emcure Pharma IPO is up to ₹1,952.03 Cr. The final issue price of Akums Drugs and Pharmaceuticals IPO is ₹679.00 per share and of Emcure Pharma IPO is ₹1,008.00 per share.

  Akums Drugs and Pharmaceuticals IPO Emcure Pharma IPO
Face Value ₹2 per share ₹10 per share
Issue Price (Lower) ₹646.00 per share ₹960.00 per share
Issue Price (Upper) ₹679.00 per share ₹1,008.00 per share
Issue Price (Final) ₹679.00 per share ₹1,008.00 per share
Discount (Retail)
Discount (Employee) ₹64.00 per share ₹90.00 per share
Market Lot Size 22 shares 14 shares
Fresh Issue Size 1,00,14,727 shares 79,36,507 shares
Fresh Issue Size (Amount) up to ₹680.00 Cr up to ₹800.00 Cr
OFS Issue Size 1,73,30,435 shares 1,14,28,839 shares
OFS Issue Size (Amount) up to ₹1,176.74 Cr up to ₹1,152.03 Cr
Issue Size Total 2,73,45,162 shares 1,93,65,346 shares
Issue Size Total (Amount) up to ₹1,856.74 Cr up to ₹1,952.03 Cr

IPO Timetable

Akums Drugs and Pharmaceuticals IPO opens on Jul 30, 2024, while Emcure Pharma IPO opens on Jul 03, 2024. The closing date of Akums Drugs and Pharmaceuticals IPO and Emcure Pharma IPO is Aug 01, 2024, and Jul 05, 2024, respectively.

  Akums Drugs and Pharmaceuticals IPO Emcure Pharma IPO
Anchor Bid Date Jul 29, 2024 Jul 02, 2024
Issue Open Jul 30, 2024 Jul 03, 2024
Issue Close Aug 01, 2024 Jul 05, 2024
Basis Of Allotment (Tentative) Aug 02, 2024 Jul 08, 2024
Initiation of Refunds (Tentative) Aug 05, 2024 Jul 09, 2024
Credit of Share (Tentative) Aug 05, 2024 Jul 09, 2024
Listing date (Tentative) Aug 06, 2024 Jul 10, 2024
Anchor Lockin End date 1 Sep 01, 2024 Aug 07, 2024
Anchor Lockin End date 2 Oct 31, 2024 Oct 06, 2024

Financials

Akums Drugs and Pharmaceuticals IPO P/E ratio is , as compared to Emcure Pharma IPO P/E ratio of 34.55.

  Akums Drugs and Pharmaceuticals IPO Emcure Pharma IPO
Financial

Akums Drugs and Pharmaceuticals Limited Financial Information (Restated Consolidated)

Akums Drugs and Pharmaceuticals Limited's revenue increased by 13.81% and profit after tax (PAT) dropped by -99.19% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended31 Mar 202431 Mar 202331 Mar 2022
Assets3,516.373,266.533,069.05
Revenue4,212.213,700.933,694.52
Profit After Tax0.7997.82-250.87
Net Worth709.50717.19621.98
Reserves and Surplus861.01868.70787.79
Total Borrowing491.56536.97357.95
Amount in ₹ Crore

Emcure Pharmaceuticals Limited Financial Information (Restated Consolidated)

Emcure Pharmaceuticals Limited's revenue increased by 11.33% and profit after tax (PAT) dropped by -6.1% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended31 Mar 202431 Mar 202331 Mar 2022
Assets7,806.166,672.536,063.47
Revenue6,715.246,031.725,918.86
Profit After Tax527.58561.85702.56
Net Worth2,952.282,501.131,987.55
Reserves and Surplus2,722.402,293.771,791.03
Total Borrowing2,091.942,202.422,102.19
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue) 84.94% 98.90%
Promoter Shareholding (Post-Issue) 78.24%
P/E Ratio 34.55
Market Cap ₹19029.89 Cr.
ROE 0.11%% 16.90%%
ROCE 3.37%% 19.37%%
Debt/Equity 0.69 0.67
EPS ₹29.17
RoNW -0.57% 16.87%%

Shares Offered

In the Akums Drugs and Pharmaceuticals IPO retail investors (RII) are offered 27,12,424 shares while in Emcure Pharma IPO retail investors are offered 27,12,424 shares. Qualified institutional buyers (QIB) are offered 81,37,276 shares in Akums Drugs and Pharmaceuticals IPO and 38,53,234 shares in Emcure Pharma IPO.

  Akums Drugs and Pharmaceuticals IPO Emcure Pharma IPO
Anchor Investor Reserveration 1,22,05,912 shares 57,79,850 shares
Market Maker Reserveration
QIB 81,37,276 shares 38,53,234 shares
NII 40,68,637 shares 28,89,926 shares
RII 27,12,424 shares 67,43,160 shares
Employee 2,43,902 shares 1,08,900 shares
Others
Total 1,51,62,239 shares 1,37,03,538 shares

Bids Received (Subscription)

Akums Drugs and Pharmaceuticals IPO subscribed 63.44x in total, whereas Emcure Pharma IPO subscribed 67.87x.

  Akums Drugs and Pharmaceuticals IPO Emcure Pharma IPO
QIB (times) 90.09x 191.24x
NII (times) 42.10x 49.32x
Big NII (times) 47.43x 54.90x
Small NII (times) 31.45x 38.16x
RII (times) 20.80x 7.36x
Employee (times) 4.14x 8.81x
Other (times)
Total (times) 63.44x 67.87x

Comments

Add a public comment...